Basic Principles in Oncology Course
18 ESCO credits
27.10.2022 - 30.10.2022
Ljubljana, Slovenia
COURSES AND SEMINARS
Description
Chairs: A. Eniu, CH – F.A. Peccatori, IT
ESO is proposing a new comprehensive course for oncology trainees in Europe intended to bridge the gap in education between courses for students and ESO’s well-known Masterclasses. The course aims to provide orientation to the guiding principles of multidisciplinary oncological management and life as a modern oncologist.
Although some of the principles underlying oncology practice are similar to those in other branches of medicine, sub-specialisation has reduced the exposure of medical students and junior residents to oncological concepts and practice. New oncology trainees face a number of specific challenges. These include navigation of an extensive curriculum with no clear starting point, a rapidly evolving clinical landscape, and increasing clinical demands. During training, residents must also strategically plan their careers, manage any academic focus, and maintain a healthy work-life balance.
Learning Outcomes
- Update on basic principles in etiology and epidemiology
- Update on basic cancer genetics, staging and imaging
- Update on basic surgical oncology and pathology
- Update on basic radiology and chemotherapy
- Intro to paediatric oncology
- Intro to tumour board and patient issues: communication, supportive and palliative care
- Intro to clinical trials and paper appraisal
Information
OFFICIAL LANGUAGE
The official language will be English. No translation will be available.
CME ACCREDITATION
The Basic Principles of Oncology Course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 20 European CME credits (ECMEC®s).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity.
The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
PARTICIPATION
Attendance is limited to 80 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO-ESMO course for medical students or the ESO-ESSO-ESTRO course for medical students.
Successful applicants are granted free registration.
Accommodation at the course venue for arrival on Thursday 27 October and departure on Sunday 30 October will be provided to participants not residing in the Ljubljana area.
ORGANISING SECRETARIAT
Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net
In partnership with |
Endorsed by |
Application
Ideal candidate:
- 1-3 years oncology training
Interested candidates should apply online providing:
- CV (template provided) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)
- Motivation letter
- Support letter from mentor or head of department
APPLICATION CLOSED
Programme
27 October | ||
13:00 | Registration | |
13:45 | Welcome address and general introduction Alexandru Eniu, CH - Fedro Alessandro Peccatori, IT | |
14:00 | Principles of cancer etiology and epidemiology Claudia Allemani , UK | |
14:30 | The hallmarks of cancer:Perspectives for cancer medicine Douglas Hanahan, CH | |
15:00 | Principles of cancer genetics Sheila Unger, CH | |
15:30 | Coffee break | |
16:00 | Basic cancer pathology Giancarlo Pruneri, IT | |
16:30 | Basic principles of imaging in cancer assesment Petra Steyerova, CZ | |
17:00 | Principles of staging systems Jasna But Hadžic, SI | |
17:30 | The art of being an oncologist: a humanistic view Franco Cavalli, CH | |
19:30 | Welcome Dinner | |
28 October | ||
8:30 | The validity of serum tumor markers in oncology Erika Matos, SI | |
9:00 | Molecular oncology: Towards precision medicine Assma Ben Aissa, CH | |
9:30 | Principles of patient assessment Ian Tannock, CA | |
10:00 | Principles of surgical oncology Isabel T. Rubio, ES | |
10:30 | Coffee break | |
11:00 | Principles of radiotherapy: Basic physics and radiobiology Primoz Strojan, SI | |
11:30 | Planning of radiotherapy, techniques and side effects Rodica Anghel, RO | |
12:00 | Principles of systemic therapy (chemotherapy/hormonal therapy/ targeted agents) Filippo De Braud, IT | |
12:30 | Basic principles of chemotherapy with toxicity Giuseppe Curigliano, IT | |
13:00 | Lunch | |
14:00 | Basic principles of targeted therapies with toxicity Tanja Cufer, SI | |
14:30 | Basic principles of immunotherapy with toxicity Filippo De Braud, IT | |
15:00 | Coffee break | |
15:30 | Principles of AYA oncology Stefan Bielack, DE | |
16:00 | Clinical case presentation and discussion Giuseppe Curigliano, IT - Laurentia Nicoleta Gales, RO - Giancarlo Pruneri, IT - Primoz Strojan, SI | |
19:30 | Free Evening | |
29 October | ||
8:30 | Basic principles of endocrine therapy with toxicity Bostjan Seruga, SI | |
9:00 | Multidisciplinary care and tumor boards Olivia Pagani, CH | |
9:30 | Cancer in the elderly Matti Aapro, CH | |
10:00 | Oncological emergencies Matteo Lambertini, IT | |
10:30 | Coffee break | |
11:00 | Infections in cancer patients, including COVID Matteo Lambertini, IT | |
11:30 | Paraneoplastic syndromes Erika Matos, SI | |
12:00 | Survivorship issues in cancer patients Olivia Pagani, CH | |
12:30 | Principles of supportive care in cancer patients Snezana Bosnjak, RS | |
13:00 | Principles of palliative care in cancer patients Florian Scotté, FR | |
13:30 | Lunch | |
14:30 | Availability and rational use of anti-cancer therapies (priorities or access to drugs) Alexandru Eniu, CH | |
15:00 | Clinical case presentation and discussion Giuseppe Curigliano, IT - Matteo Lambertini, IT - Erika Matos, SI - Florian Scotté, FR | |
16:30 | Coffee break | |
17:00 | Principles of communication with the cancer patients Luzia Travado, PT | |
17:30 | Introduction to clinical trials Tanja Cufer, SI | |
18:00 | Critical appraisal of papers Ian Tannock, CA | |
18:30 | Free Evening | |
30 October | ||
8:30 | The future of oncology - round table discussion Claudia Allemani , UK - Tanja Cufer, SI - Alexandru Eniu, CH - Bostjan Seruga, SI | |
9:15 | Career planning and opportunities - round table discussion Tanja Cufer, SI - Bostjan Seruga, SI - Ian Tannock, CA - Janez Zgajnar, SI | |
10:00 | Coffee break | |
10:30 | Self-assessment test | |
11:30 | Closing remarks and awards | |
12:00 | Departures |
Faculty
Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Claudia Allemani, London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK
Rodica Anghel, Institute of Oncology "Prof. Dr. Al Trestioreanu", -, Bucharest, RO
Assma Ben Aissa, Geneva University Hospital, Oncology Department, Geneva, CH
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Jasna But Hadžic, University of Ljubljana, Oncology and Radiotherapy Dept., Ljubljana, SI
Franco Cavalli, Oncology Institute of Southern Switzerland, Ufficio Prof. Cavalli, Bellinzona, CH
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Filippo De Braud, University of Milan, Milan, IT
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Laurentia Nicoleta Gales, Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu", Oncology Dept., Bucharest, RO
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, School of Life Sciences, Lausanne, CH
Matteo Lambertini, Policlinico San Martino Hospital – University of Genoa, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, Genoa, IT
Erika Matos, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Isabel T. Rubio, Clínica Universidad de Navarra, Breast Surgical Oncology Dpt., Madrid, ES
Florian Scotté, Institute Gustave Roussy, Medical Oncology and supportive care department, Villejuif, FR
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ
Primoz Strojan, Institute of Oncology, Dept.of Radiation Oncology, Ljubljana, SI
Ian Tannock, Princess Margaret Hospital, Dept. of Oncology and Hematology, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Centre For the Unknown, Lisbon, PT
Sheila Unger, University Hospital Centre Vaudois, Genetic Medicine Department, Lausanne, CH
Janez Zgajnar, Institute of Oncology Ljubljana, Dept. of Surgical Oncology, Ljubljana, SI